| A catalog of associations between rare coding variants and COVID-19 outcomes JA Kosmicki, JE Horowitz, N Banerjee, R Lanche, A Marcketta, E Maxwell, ... medRxiv, 2021 | 16 | 2021 |
| A catalog of associations between rare coding variants and COVID-19 outcomes (preprint) JA Kosmicki, JE Horowitz, N Banerjee, R Lanche, A Marcketta, E Maxwell, ... | | 2021 |
| A community challenge to predict clinical outcomes after immune checkpoint blockade in non-small cell lung cancer M Mason, Ó Lapuente-Santana, AS Halkola, W Wang, R Mall, X Xiao, ... Journal of Translational Medicine 22 (1), 190, 2024 | 4 | 2024 |
| A protein structure alignment method and application to the discovery of recurrent protein structure motifs JD Szustakowski Boston University, 2003 | 6 | 2003 |
| Abstract CT077: Nivolumab (Nivo)+ ipilimumab (Ipi) vs platinum-doublet chemotherapy (PT-DC) as first-line (1L) treatment (Tx) for advanced non-small cell lung cancer (NSCLC … MD Hellmann, TE Ciuleanu, A Pluzanski, JS Lee, G Otterson, ... Cancer Research 78 (13_Supplement), CT077-CT077, 2018 | 14 | 2018 |
| Abstract CT078: Tumor mutational burden (TMB) as a biomarker for clinical benefit from dual immune checkpoint blockade with nivolumab (nivo)+ ipilimumab (ipi) in first-line (1L … SS Ramalingam, MD Hellmann, MM Awad, H Borghaei, J Gainor, ... Cancer Research 78 (13_Supplement), CT078-CT078, 2018 | 41 | 2018 |
| Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank JD Szustakowski, S Balasubramanian, E Kvikstad, S Khalid, PG Bronson, ... Nature genetics 53 (7), 942-948, 2021 | 290 | 2021 |
| Anti-pd-1 antibody for use in a method of treating a tumor R Edwards, H Chang, M Cleary, PM Szabo, JD Szustakowski, P Vitazka US Patent App. 17/699,949, 2022 | | 2022 |
| Anti-pd-1 antibody for use in a method of treating a tumor R EDWARDS, H Chang, M Cleary, PM SZABO, JD SZUSTAKOWSKI, ... | | 2017 |
| Anti-pd-1 antibody for use in a method of treating a tumor R Edwards, H Chang, M Cleary, PM Szabo, JD Szustakowski, P Vitazka US Patent App. 16/306,380, 2020 | 1 | 2020 |
| Bioinformatic methods and bridging of assay results for reliable tumor mutational burden assessment in non-small-cell lung cancer H Chang, A Sasson, S Srinivasan, R Golhar, DM Greenawalt, WJ Geese, ... Molecular diagnosis & therapy 23, 507-520, 2019 | 49 | 2019 |
| Bioinformatics analysis of microarray data Y Zhang, J Szustakowski, M Schinke Cardiovascular Genomics: Methods and Protocols, 259-284, 2009 | 73 | 2009 |
| Characterization of additional cochlear ESTs for gene discovery in the auditory system. BL Resendes, NG Robertson, JD Szustakowski, RJ Resendes, Z Weng, ... AMERICAN JOURNAL OF HUMAN GENETICS 67 (4), 384-384, 2000 | | 2000 |
| Clustering protein sequences with a novel metric transformed from sequence similarity scores and sequence alignments with neural networks Q Ma, GW Chirn, R Cai, JD Szustakowski, NR Nirmala BMC bioinformatics 6, 1-13, 2005 | 20 | 2005 |
| Computational identification of operons in microbial genomes Y Zheng, JD Szustakowski, L Fortnow, RJ Roberts, S Kasif Genome research 12 (8), 1221-1230, 2002 | 196 | 2002 |
| Cross-platform integrative analysis of NSCLC reveals association between PD-L1 expression patterns and tumor genetic profile R Edwards, P Vitazka, P Szabo, H Chang, J Cogswell, H Tang, K Desai, ... Cancer Research 77 (13_Supplement), 593-593, 2017 | | 2017 |
| DeconRNASeq: a statistical framework for deconvolution of heterogeneous tissue samples based on mRNA-Seq data T Gong, JD Szustakowski Bioinformatics 29 (8), 1083-1085, 2013 | 285 | 2013 |
| Duplicated enhancer region increases expression of CTSB and segregates with keratolytic winter erythema in South African and Norwegian families T Ngcungcu, M Oti, JC Sitek, BI Haukanes, B Linghu, R Bruccoleri, ... The American Journal of Human Genetics 100 (5), 737-750, 2017 | 37 | 2017 |
| Dynamic resolution of functionally related gene sets in response to acute heat stress JD Szustakowski, PA Kosinski, CA Marrese, JH Lee, SJ Elliman, ... BMC molecular biology 8, 1-9, 2007 | 13 | 2007 |
| Early signs of immune response and pro-fibrotic events in renal allograft protocol biopsies three months before chronic allograft damage. A Scherer, W Gwinner, T Kirsch, M Mengel, JD Szustakowski, G Engel, ... AMERICAN JOURNAL OF TRANSPLANTATION 7, 181-181, 2007 | | 2007 |
Matthew HellmannMemorial Sloan Kettering Cancer Center在 mskcc.org 的电子邮件经过验证
